Centiva Capital LP Buys 146,033 Shares of Healthcare Realty Trust Incorporated (NYSE:HR)

Centiva Capital LP increased its stake in Healthcare Realty Trust Incorporated (NYSE:HRFree Report) by 340.7% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 188,899 shares of the real estate investment trust’s stock after acquiring an additional 146,033 shares during the period. Centiva Capital LP owned about 0.05% of Healthcare Realty Trust worth $3,429,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in HR. Cinctive Capital Management LP purchased a new position in shares of Healthcare Realty Trust in the 3rd quarter worth about $4,257,000. Point72 Asia Singapore Pte. Ltd. raised its holdings in shares of Healthcare Realty Trust by 222.7% during the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 53,130 shares of the real estate investment trust’s stock valued at $964,000 after buying an additional 36,666 shares in the last quarter. Point72 Hong Kong Ltd bought a new stake in Healthcare Realty Trust in the 3rd quarter worth approximately $65,000. Verition Fund Management LLC boosted its stake in Healthcare Realty Trust by 3.7% in the third quarter. Verition Fund Management LLC now owns 60,936 shares of the real estate investment trust’s stock worth $1,106,000 after buying an additional 2,159 shares in the last quarter. Finally, Captrust Financial Advisors grew its position in Healthcare Realty Trust by 27.2% during the third quarter. Captrust Financial Advisors now owns 31,562 shares of the real estate investment trust’s stock valued at $573,000 after acquiring an additional 6,747 shares during the last quarter.

Insider Activity

In other Healthcare Realty Trust news, Director John Knox Singleton purchased 6,500 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The stock was bought at an average price of $18.24 per share, with a total value of $118,560.00. Following the completion of the purchase, the director now directly owns 57,082 shares of the company’s stock, valued at $1,041,175.68. The trade was a 12.85 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Thomas N. Bohjalian acquired 7,750 shares of Healthcare Realty Trust stock in a transaction on Friday, November 22nd. The shares were bought at an average cost of $17.39 per share, for a total transaction of $134,772.50. Following the completion of the transaction, the director now owns 50,002 shares in the company, valued at approximately $869,534.78. This trade represents a 18.34 % increase in their position. The disclosure for this purchase can be found here. Insiders own 0.56% of the company’s stock.

Healthcare Realty Trust Stock Down 0.9 %

Shares of NYSE HR opened at $18.32 on Monday. The firm’s fifty day moving average is $17.75 and its 200 day moving average is $17.35. Healthcare Realty Trust Incorporated has a 52 week low of $12.77 and a 52 week high of $18.90. The company has a market cap of $6.49 billion, a price-to-earnings ratio of -11.59 and a beta of 0.91.

Healthcare Realty Trust Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, November 27th. Shareholders of record on Tuesday, November 12th were given a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a dividend yield of 6.77%. The ex-dividend date was Tuesday, November 12th. Healthcare Realty Trust’s payout ratio is -78.48%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on HR. Wedbush boosted their price objective on shares of Healthcare Realty Trust from $15.00 to $18.00 and gave the stock a “neutral” rating in a report on Monday, August 5th. Scotiabank lifted their target price on shares of Healthcare Realty Trust from $17.00 to $18.00 and gave the stock a “sector perform” rating in a research report on Wednesday, August 7th. Finally, Wells Fargo & Company restated an “underweight” rating and set a $17.00 price target (up from $16.00) on shares of Healthcare Realty Trust in a research report on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $17.17.

Get Our Latest Stock Analysis on HR

Healthcare Realty Trust Profile

(Free Report)

Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes more than 700 properties totaling over 40 million square feet concentrated in 15 growth markets.

Read More

Institutional Ownership by Quarter for Healthcare Realty Trust (NYSE:HR)

Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.